Increasing Participation of Women in Early Phase Clinical Trials Approved by the FDA

Background Historically women were excluded from participation in phase 1 clinical trials. The goal of this study was to determine the participation of women and evaluate if participation has increased over time. Methods Clinical trial data submitted to the FDA for New Molecular Entities (NMEs) for...

Ausführliche Beschreibung